Metabolic plasticity in castration-resistant prostate cancer: reprogramming mechanisms and therapeutic opportunities
Cellular Signalling · 2027-01 · 149 · 112885
DOI: 10.1016/j.cellsig.2026.112885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Yanzhi Lou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Yiwu Central Hospital, Jinhua 322000, Zhejiang, China. Die Arbeit nennt 123 Literaturangaben.
Abstract (Originalsprache)
Prostate cancer (PCa) is one of the most common malignant tumors, and most patients develop castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT). Metabolic plasticity, which allows cancer cells to reprogram glucose, lipid, and glutamine utilization, plays a key role. This metabolic adaptation meets the bioenergetic and biosynthetic needs of tumor cells, and it can interact with the androgen receptor (AR) signaling pathway bidirectionally to evade immune surveillance via metabolic reprogramming. Current treatments include single metabolic node inhibition and AR-guided combination therapy. However, due to intratumoral metabolic heterogeneity, compensatory pathway activation, and systemic metabolic toxicity of drugs, there is a need to explore new intervention targets and strategies. This article comprehensively discusses the metabolic network, regulatory mechanism, and current challenges of CRPC in order to provide a theoretical basis for clinical prevention and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Yiwu Central Hospital, Jinhua 322000, Zhejiang, China.
- Department of Urology, Yiwu Central Hospital, Jinhua 322000, Zhejiang, China. Electronic address: 15067041502@163.com.
Zitieren
APA
Lou, Y., Lou, Z., He, L., & Luo, J. (2027). Metabolic plasticity in castration-resistant prostate cancer: reprogramming mechanisms and therapeutic opportunities. Cellular Signalling, 149, 112885. https://doi.org/10.1016/j.cellsig.2026.112885
Vancouver
Lou Y, Lou Z, He L, Luo J. Metabolic plasticity in castration-resistant prostate cancer: reprogramming mechanisms and therapeutic opportunities. Cellular Signalling. 2027;149:112885. doi:10.1016/j.cellsig.2026.112885
BibTeX
@article{Lou2027,
author = {Lou, Yanzhi and Lou, Zhengda and He, Luo and Luo, Junfeng},
title = {Metabolic plasticity in castration-resistant prostate cancer: reprogramming mechanisms and therapeutic opportunities},
journal = {Cellular Signalling},
year = {2027},
volume = {149},
pages = {112885},
doi = {10.1016/j.cellsig.2026.112885}
}
EUVIMED